Desmopressin Acetate
- Product NDC
- 70771-1314
- 11-digit product format
- 707711314
- Labeler code
- 70771
- Product ID
- 70771-1314_d7ff2b95-b76f-4587-a38a-4de57dd2c726
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desmopressin Acetate
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA091345
- Marketing category
- ANDA
- Marketing start
- 2018-02-01
- Marketing end
- 0000-00-00
- Substance
- DESMOPRESSIN ACETATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1314-1 | 70771131401 | 5 mL in 1 BOTTLE, SPRAY (70771-1314-1) | 5 ml | 2018-02-01 | 0000-00-00 | No | No | Current |